How Biogen Inc.'s share price moved after each results release, and its latest quarters.
Biogen Inc. has moved on average 3.56% (up or down) on the trading day after its last 4 results, and rose after 5 of its last 8. The biggest move was a rise of 8.5% on 6 Feb 2026. At today's price of $253.40, an average-sized move would be about $9.02 a share.
| Results filed | Opened | Closed |
|---|---|---|
| 28 Oct 2026 | -3.09% | -3.43% |
| 29 Jul 2026 | +2.38% | +1.76% |
| 1 Jul 2026 | +1.43% | +3.04% |
| 29 Apr 2026 | -0.14% | +6.00% |
| 6 Apr 2026 | -0.19% | -2.82% |
| 6 Feb 2026 | +0.89% | +8.53% |
| 13 Jan 2026 | -0.32% | -5.04% |
| 30 Oct 2025 | -5.25% | +1.18% |
Against the close before the release. A release before the 16:00 New York close counts that day; after the close, the next trading day.
| Quarter ended | Revenue | Profit | EPS |
|---|---|---|---|
| 30 Sept 2026 | $2.80 B | $-21 M | $-0.14 |
| 30 Jun 2026 | $2.74 B | $98 M | $0.66 |
| 31 Mar 2026 | $2.48 B | $320 M | $2.15 |
| 31 Dec 2025 | $2.28 B | $-49 M | $-0.35 |
| 30 Sept 2025 | $2.53 B | $467 M | $3.17 |
| 30 Jun 2025 | $2.65 B | $635 M | $4.33 |
| 31 Mar 2025 | $2.43 B | $241 M | $1.64 |
| 31 Dec 2024 | $2.45 B | $267 M | $1.82 |
From the company's SEC filings (10-Q and 10-K).
Biogen Inc. stock page › · Earnings calendar ›
Release times from SEC filings; next date and EPS estimate from Nasdaq's earnings calendar; prices from all US exchanges. Information only, not investment advice.
On average 3.56% (up or down) on the trading day after its last 4 results, from its SEC filing times and daily closes.
Not announced yet. Companies usually report about 3 to 6 weeks after each quarter ends.